Shandong Luye Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SHANDONG LUYE
SHANDONG LUYE has one approved drug.
There are five US patents protecting SHANDONG LUYE drugs.
There are twenty-nine patent family members on SHANDONG LUYE drugs in fourteen countries and one supplementary protection certificate in one country.
Summary for Shandong Luye
| International Patents: | 29 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Shandong Luye
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-001 | Jan 13, 2023 | DISCN | Yes | No | 9,532,991 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-002 | Jan 13, 2023 | RX | Yes | Yes | 9,446,135 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-003 | Jan 13, 2023 | RX | Yes | No | 10,098,882 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-003 | Jan 13, 2023 | RX | Yes | No | 10,406,161 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-001 | Jan 13, 2023 | DISCN | Yes | No | 10,098,882 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-001 | Jan 13, 2023 | DISCN | Yes | No | 11,110,094 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Shandong Luye Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 101539313 | ⤷ Start Trial |
| Brazil | 112013027235 | ⤷ Start Trial |
| Poland | 3199146 | ⤷ Start Trial |
| Spain | 2607497 | ⤷ Start Trial |
| Hong Kong | 1185560 | ⤷ Start Trial |
| Russian Federation | 2013147949 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Shandong Luye Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0196132 | 94C0008 | Belgium | ⤷ Start Trial | PRODUCT NAME: RISPERIDONE; NAT REG.: 2 S 414 F 3 19940527; FIRST REG.: GB 0242/0186 19921208 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
